KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $10.7 billion.

  • Bristol Myers Squibb's Cash & Current Investments fell 171.29% to $10.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $10.7 billion, marking a year-over-year decrease of 171.29%. This contributed to the annual value of $10.7 billion for FY2025, which is 171.29% down from last year.
  • Per Bristol Myers Squibb's latest filing, its Cash & Current Investments stood at $10.7 billion for Q4 2025, which was down 171.29% from $16.5 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Cash & Current Investments ranged from a high of $17.0 billion in Q4 2021 and a low of $6.7 billion during Q2 2024
  • Over the past 5 years, Bristol Myers Squibb's median Cash & Current Investments value was $11.3 billion (recorded in 2024), while the average stood at $11.5 billion.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first plummeted by 4546.15% in 2022, then skyrocketed by 10446.42% in 2025.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Cash & Current Investments stood at $17.0 billion in 2021, then crashed by 45.46% to $9.3 billion in 2022, then skyrocketed by 32.71% to $12.3 billion in 2023, then fell by 11.57% to $10.9 billion in 2024, then fell by 1.71% to $10.7 billion in 2025.
  • Its Cash & Current Investments was $10.7 billion in Q4 2025, compared to $16.5 billion in Q3 2025 and $13.6 billion in Q2 2025.